Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

LH, FSH, TT, FT, Tmax, AST, GGT, BUN, Cr, UA, TG, TC, HDL-C, LDL-C, FBG, 2hPG, 25(OH)D, and PTH did not differ significantly with respect to the OC quartiles.

Source: Baseline Clinical Characteristics of IHH Patients by Quartiles of Serum OC Levels. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Ninety-nine male patients aged 18 to 37 years and diagnosed with IHH according to the American Association of Clinical Endocrinologists Medical Guidelines () were consecutively recruited from the outpatient service of the Department of Endocrine and Metabolic Diseases, Rui-jin Hospital.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles

Study design awaiting verification · Frontiers in Endocrinology · 2019

Original publication title

Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles

Yu-Ying Yang; Si-Chang Zheng; Wen-Cui Wang; Zu-Wei Yang; Chang Shan; Yu-Wen Zhang; Yan Qi; Yu-Hong Chen; Wei-Qiong Gu; Wei-Qing Wang; Hong-Yan Zhao; Jian-Min Liu; Shou-Yue Sun

Copyright © 2019 Yang, Zheng, Wang, Yang, Shan, Zhang, Qi, Chen, Gu, Wang, Zhao, Liu and Sun.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Idiopathic hypogonadotropic hypogonadism (IHH) patients are characterized by the absence of puberty and varying degrees of deteriorated metabolic conditions. Osteocalcin (OC) could regulate testosterone secretion and energy metabolism, but it remains unknown whether such an effect exists in IHH patients. Our study is aimed to examine the relationship between serum OC levels with testosterone and its responsiveness to gonadotropin stimulation and metabolic profiles in male IHH patients. A total of 99 male patients aged 18 to 37 years and diagnosed with IHH were enrolled in the current study, and the relationships between OC and testicular volume, baseline total testosterone (TT), free testosterone (FT), and peak TT (Tmax) levels after human chorionic gonadotropin (hCG) stimulation, gonadotropin responsiveness index (GRI), which is calculated by dividing Tmax by testicular volume, as well as metabolic profiles, such as 2-h post-challenge glucose (2hPG) and fat percentage (fat%), were analyzed.

The results showed that OC had an independent negative relationship with testicular volume (r = −0.253, P = 0.012) and a positive association with Tmax (r = 0.262, P = 0.014) after adjusting for confounders. In addition, OC was a major determinant of GRI (adjusted R2 for the model = 0.164, P = 0.012), fat% (adjusted R2 for the model = 0.100, P = 0.004), and 2hPG (adjusted R2 for the model = 0.054, P = 0.013) in IHH patients.

In conclusion, OC is associated with testosterone secretion upon gonadotropin stimulation, glucose metabolism, and fat mass variations in IHH. This study was registered at clinicaltrials.gov (NCT02310074).

Authors’ abstract

Idiopathic hypogonadotropic hypogonadism (IHH) patients are characterized by the absence of puberty and varying degrees of deteriorated metabolic conditions. Osteocalcin (OC) could regulate testosterone secretion and energy metabolism, but it remains unknown whether such an effect exists in IHH patients. Our study is aimed to examine the relationship between serum OC levels with testosterone and its responsiveness to gonadotropin stimulation and metabolic profiles in male IHH patients. A total of 99 male patients aged 18 to 37 years and diagnosed with IHH were enrolled in the current study, and the relationships between OC and testicular volume, baseline total testosterone (TT), free testosterone (FT), and peak TT (Tmax) levels after human chorionic gonadotropin (hCG) stimulation, gonadotropin responsiveness index (GRI), which is calculated by dividing Tmax by testicular volume, as well as metabolic profiles, such as 2-h post-challenge glucose (2hPG) and fat percentage (fat%), were analyzed.

The results showed that OC had an independent negative relationship with testicular volume (r = −0.253, P = 0.012) and a positive association with Tmax (r = 0.262, P = 0.014) after adjusting for confounders. In addition, OC was a major determinant of GRI (adjusted R2 for the model = 0.164, P = 0.012), fat% (adjusted R2 for the model = 0.100, P = 0.004), and 2hPG (adjusted R2 for the model = 0.054, P = 0.013) in IHH patients.

In conclusion, OC is associated with testosterone secretion upon gonadotropin stimulation, glucose metabolism, and fat mass variations in IHH. This study was registered at clinicaltrials.gov (NCT02310074).

Publication and source details

Original title: Osteocalcin Levels in Male Idiopathic Hypogonadotropic Hypogonadism: Relationship With the Testosterone Secretion and Metabolic Profiles

Yu-Ying Yang; Si-Chang Zheng; Wen-Cui Wang; Zu-Wei Yang; Chang Shan; Yu-Wen Zhang; Yan Qi; Yu-Hong Chen; Wei-Qiong Gu; Wei-Qing Wang; Hong-Yan Zhao; Jian-Min Liu; Shou-Yue Sun

Frontiers in Endocrinology · 2019

Edited by: Andrea Del Fattore, Bambino Gesù Children Hospital (IRCCS), Italy

Reviewed by: Luca De Toni, University of Padova, Italy; Michaël R. Laurent, University Hospitals Leuven, Belgium

*Correspondence: Jian-Min Liu ljm10586@rjh.com.cnShou-Yue Sun ssy10926@rjh.com.cn

This article was submitted to Bone Research, a section of the journal Frontiers in Endocrinology

†These authors have contributed equally to this work

Copyright © 2019 Yang, Zheng, Wang, Yang, Shan, Zhang, Qi, Chen, Gu, Wang, Zhao, Liu and Sun.2019Yang, Zheng, Wang, Yang, Shan, Zhang, Qi, Chen, Gu, Wang, Zhao, Liu and Sunhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T18:20:11.392717+00:00

DOI: 10.3389/fendo.2019.00687 · PMC6798147